NovelFGF8Mutations Associated with Recessive Holoprosencephaly, Craniofacial Defects, and Hypothalamo-Pituitary Dysfunction
Author(s) -
Mark J. McCabe,
Carles GastonMassuet,
Vaitsa Tziaferi,
Louise Gregory,
Kyriaki S. Alatzoglou,
Massimo Signore,
Eduardo Puelles,
Dianne Gerrelli,
I. Sadaf Farooqi,
Jamal Raza,
Joanna Walker,
Scott I. Kavanaugh,
PeiSan Tsai,
Nelly Pitteloud,
Juan Pedro Martı́nez-Barberá,
Mehul Dattani
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-0454
Subject(s) - holoprosencephaly , fgf8 , context (archaeology) , craniofacial , kallmann syndrome , fibroblast growth factor , biology , short stature , endocrinology , fibroblast growth factor receptor 1 , etiology , medicine , hypogonadotropic hypogonadism , genetics , pregnancy , hormone , fetus , disease , receptor , paleontology , covid-19 , infectious disease (medical specialty)
Fibroblast growth factor (FGF) 8 is important for GnRH neuronal development with human mutations resulting in Kallmann syndrome. Murine data suggest a role for Fgf8 in hypothalamo-pituitary development; however, its role in the etiology of wider hypothalamo-pituitary dysfunction in humans is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom